首页> 外文期刊>International Journal of Nanomedicine >Effect of magnetic nanoparticles of Fe3O4 and wogonin on the reversal of multidrug resistance in K562/A02 cell line
【24h】

Effect of magnetic nanoparticles of Fe3O4 and wogonin on the reversal of multidrug resistance in K562/A02 cell line

机译:Fe3O4和wogonin磁性纳米粒子对K562 / A02细胞株多药耐药性逆转的影响

获取原文
           

摘要

Background: Multidrug resistance is the main obstacle to the efficiency of systemic chemotherapy against hematologic malignancy. This study investigated the reversible effect of the copolymer wogonin and daunorubicin coloaded into Fe3O4 magnetic anoparticles, and the mechanism potentially involved.Methods: The growth inhibition rate of K562/A02 cells was investigated by MTT assay, and apoptosis of cells and the intracellular daunorubicin concentration were detected by flow cytometry. Distribution of nanoparticles taken up by K562/A02 cells was observed under a transmission electron microscope and demonstrated by Prussian blue staining. The transcription level of MDR1 mRNA and expression of P-glycoprotein were determined by reverse transcriptase polymerase chain reaction and Western blotting assay, respectively.Results: The reversible effect of daunorubicin-wogonin magnetic nanoparticles was 8.87-fold that of daunorubicin + wogonin and of daunorubicin magnetic nanoparticles. Transmission electron microscopy and Prussian blue staining revealed that the nanoparticles were located in the endosome vesicles of cytoplasm. Also, the apoptosis rate and accumulation of intracellular daunorubicin in the daunorubicin-wogonin magnetic nanoparticle group were significantly higher than that in the daunorubicin, daunorubicin + wogonin, and daunorubicin magnetic nanoparticle groups. Furthermore, transcription of MDR1 mRNA and expression of P-glycoprotein in K562/A02 cells were significantly downregulated in the daunorubicin-wogonin magnetic nanoparticle group compared with the other groups.Conclusion: These findings suggest that the remarkable effects of the novel daunorubicin-wogonin magnetic nanoparticle formulation on multidrug resistant K562/A02 leukemia cells would be a promising strategy for overcoming multidrug resistance.
机译:背景:多药耐药性是全身化疗抗血液系统恶性肿瘤的主要障碍。本研究探讨了共窝伍宁和柔红霉素共载于Fe3O4磁性纳米粒子中的可逆作用及其可能的机制。方法:采用MTT法研究了K562 / A02细胞的生长抑制率,细胞凋亡及细胞内柔红霉素浓度。通过流式细胞仪检测。在透射电子显微镜下观察到K562 / A02细胞吸收的纳米颗粒的分布,并通过普鲁士蓝染色证明。通过逆转录酶聚合酶链反应和蛋白质印迹法分别测定了MDR1 mRNA的转录水平和P-糖蛋白的表达。结果:柔红霉素-沃戈宁磁性纳米颗粒的可逆性是柔红霉素+沃戈宁和柔红霉素的可逆性的8.87倍。磁性纳米粒子。透射电子显微镜和普鲁士蓝染色显示,纳米颗粒位于细胞质的内体囊泡中。此外,柔红霉素-沃戈宁磁性纳米颗粒组中细胞内柔红霉素的凋亡率和细胞内蓄积明显高于柔红霉素,柔红霉素+沃戈宁和柔红霉素磁性纳米颗粒组。此外,柔红霉素-沃戈宁磁性纳米颗粒组与其他组相比,K562 / A02细胞中MDR1 mRNA的转录和P-糖蛋白的表达显着下调。结论:这些发现表明,新型柔红霉素-沃戈宁磁性磁性蛋白具有显着的作用。多药耐药性K562 / A02白血病细胞上的纳米颗粒制剂将是克服多药耐药性的一种有前途的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号